Clinical-scale in vitro expansion preserves biological characteristics of cardiac atrial appendage stem cells

Cell Proliferation

Volumn 48, Issue 2, 2015, Pages 175-186

  Windmolders, S ^a,b   Willems, L ^a,b   Daniels A ^a   Linsen, L ^a,b,c   Fanton, Y ^a,b   Hendrikx, M ^a,b   Koninckx, R ^a,b   Rummens, J L ^a,b,c   Hensen, K ^a,b  

^a JESSA HOSPITAL   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c University Biobank Limburg   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; THROMBOCYTE CONCENTRATE;

AGED; ARTICLE; CARDIAC STEM CELL; CELL AGING; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELLULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLOGY; FEMALE; FETAL CALF SERUM; HEART ATRIUM APPENDAGE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; MALE; SENESCENCE; STEM CELL EXPANSION; SUPERNATANT; TELOMERE SHORTENING; THROMBOCYTE; CELL CYCLE; CULTURE TECHNIQUE; HEART VENTRICLE REMODELING; METABOLISM; MYOCARDIAL INFARCTION; PHYSIOLOGY; PROCEDURES; REGENERATION; STEM CELL;

AGED; ATRIAL APPENDAGE; BLOOD PLATELETS; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOPHENOTYPING; MALE; MYOCARDIAL INFARCTION; REGENERATION; STEM CELLS; TELOMERASE; TELOMERE SHORTENING; VENTRICULAR REMODELING;

EID: 84924005605     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12166     Document Type: Article

References (38)

1. Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, Chien KR et al. (2007) Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445, 177-182.
2. Itzhaki-Alfia A, Leor J, Raanani E, Sternik L, Spiegelstein D, Netser S et al. (2009) Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells. Circulation 120, 2559-2566.
3. Leinonen JV, Emanuelov AK, Platt Y, Helman Y, Feinberg Y, Lotan C et al. (2013) Left atrial appendages from adult hearts contain a reservoir of diverse cardiac progenitor cells. PLoS One 8, e59228.
4. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A et al. (2007) Human cardiac stem cells. Proc. Natl. Acad. Sci. USA 104, 14068-14073.
5. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E et al. (2007) Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115, 896-908.
6. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S et al. (2005) Postnatal isl1 + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647-653.
7. Bolli R, Tang XL, Sanganalmath SK, Rimoldi O, Mosna F, Abdel-Latif A et al. (2013) Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 128, 122-131.
8. Johnston PV, Sasano T, Mills K, Evers R, Lee ST, Smith RR et al. (2009) Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 120, 1075-1083, 7 p following 83.
9. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J et al. (2012) Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 126(11 Suppl 1), S54-S64.
10. Malliaras K, Makkar RR, Smith RR, Cheng K, Wu E, Bonow RO et al. (2014) Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J. Am. Coll. Cardiol. 63, 110-122.
11. Koninckx R, Daniels A, Windmolders S, Mees U, Macianskiene R, Mubagwa K et al. (2013) The cardiac atrial appendage stem cell: a new and promising candidate for myocardial repair. Cardiovasc. Res. 97, 413-423.
12. Bell GI, Broughton HC, Levac KD, Allan DA, Xenocostas A, Hess DA (2012) Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. Stem Cells Dev. 21, 97-109.
13. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R et al. (2006) Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 24, 975-985.
14. Gentry T, Deibert E, Foster SJ, Haley R, Kurtzberg J, Balber AE (2007) Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood. Cytotherapy 9, 569-576.
15. Sundin M, Ringden O, Sundberg B, Nava S, Gotherstrom C, Le Blanc K (2007) No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 92, 1208-1215.
16. Heiskanen A, Satomaa T, Tiitinen S, Laitinen A, Mannelin S, Impola U et al. (2007) N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25, 197-202.
17. Tekkatte C, Gunasingh GP, Cherian KM, Sankaranarayanan K (2011) "Humanized" stem cell culture techniques: the animal serum controversy. Stem Cells Int. 2011, 504723.
18. Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D et al. (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27, 2331-2341.
19. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X et al. (2005) Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J. Cell. Physiol. 205, 228-236.
20. Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E et al. (2007) Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47, 1436-1446.
21. Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC (1998) Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc. Natl. Acad. Sci. USA 95, 10614-10619.
22. Nekanti U, Dastidar S, Venugopal P, Totey S, Ta M (2010) Increased proliferation and analysis of differential gene expression in human Wharton's jelly-derived mesenchymal stromal cells under hypoxia. Int. J. Biol. Sci. 6, 499-512.
23. Koninckx R, Hensen K, Daniels A, Moreels M, Lambrichts I, Jongen H et al. (2009) Human bone marrow stem cells co-cultured with neonatal rat cardiomyocytes display limited cardiomyogenic plasticity. Cytotherapy 22, 1-15.
24. Larsson I, Lundgren E, Nilsson K, Strannegard O (1979) A human neoplastic hematopoietic cell line producing a fibroblast type of interferon. Dev. Biol. Stand. 42, 193-197.
25. Cawthon RM (2009) Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 37, e21.
26. O'Callaghan NJ, Fenech M (2011) A quantitative PCR method for measuring absolute telomere length. Biol. Proced. Online 13, 3.
27. Anedchenko E, Oparina N, Dmitriev A, Krasnov G, Pavlova L, Alexandrova N et al. (2008) Activation of the hTERT expression in squamous cell cervical carcinoma is not associated with gene amplification. Oncol. Rep. 20, 469-474.
28. Bajpai VK, Mistriotis P, Andreadis ST (2012) Clonal multipotency and effect of long-term in vitro expansion on differentiation potential of human hair follicle derived mesenchymal stem cells. Stem Cell Res. 8, 74-84.
29. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S et al. (2011) Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378, 1847-1857.
30. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D et al. (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379, 895-904.
31. Sussman MA, Anversa P (2004) Myocardial aging and senescence: where have the stem cells gone? Annu. Rev. Physiol. 66, 29-48.
32. Anversa P, Rota M, Urbanek K, Hosoda T, Sonnenblick EH, Leri A et al. (2005) Myocardial aging - a stem cell problem. Basic Res. Cardiol. 100, 482-493.
33. Selvaggi TA, Walker RE, Fleisher TA (1997) Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89, 776-779.
34. Halme DG, Kessler DA (2006) FDA regulation of stem-cell-based therapies. N. Engl. J. Med. 355, 1730-1735.
35. Gottipamula S, Sharma A, Krishnamurthy S, Majumdar AS, Seetharam RN (2012) Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells. Biotechnol. Lett. 34, 1367-1374.
36. Perez-Ilzarbe M, Diez-Campelo M, Aranda P, Tabera S, Lopez T, del Canizo C et al. (2009) Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion 49, 1901-1910.
37. Zimmermann R, Jakubietz R, Jakubietz M, Strasser E, Schlegel A, Wiltfang J et al. (2001) Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion 41, 1217-1224.
38. Mirabet V, Solves P, Minana MD, Encabo A, Carbonell-Uberos F, Blanquer A et al. (2008) Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues. Cell Tissue Banking 9, 1-10.